The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a purge of diversity, equity and inclusion efforts at U.S. health agencies.

Four oncologists from the Sarah Cannon Research Institute in Tennessee shared with Fox News Digital what they see as the most notable accomplishments from 2024 and what's on the horizon for 2025.

Leaked internal documents show that the insurance giant is culling providers of applied behavior analysis from its network and scrutinizing the medical necessity of therapy. Advocates say the company’...

You likely have the right to access records that explain why your insurer denied your claim or prior authorization request. Use ProPublica’s free tool to generate a letter requesting your claim file f...

Information on the Medical College of Wisconsin Infectious Disease Fellowship program.

RELAY, a global double-blind, placebo-controlled Phase 3 study (NCT02411448) demonstrated statistically significant improvement in progression-free survival (PFS; primary endpoint) for ramucirumab (RA...

ALT: a man in a hard hat is holding a trash can with the words rise and shine on the bottom